Yumiko Kagawa Selected Research

Yumiko Kagawa Research Topics

Disease

12	Neoplasms (Cancer) 02/2021 - 07/2007
5	Lymphoma (Lymphomas) 09/2019 - 09/2011
3	Polyps 10/2020 - 03/2017
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2017 - 10/2016
3	Melanoma (Melanoma, Malignant) 01/2017 - 01/2016
3	Enteritis 09/2014 - 07/2013
2	Neoplasm Metastasis (Metastasis) 12/2021 - 12/2017
2	Histiocytic Sarcoma 11/2021 - 01/2011
2	Plasmacytoma 09/2019 - 09/2011
2	Paratuberculosis (Johne's Disease) 01/2018 - 01/2016
2	Infections 12/2013 - 05/2008
1	Osteogenesis Imperfecta (Lobstein Disease) 05/2022
1	Hypoglycemia (Reactive Hypoglycemia) 03/2022
1	Lymphatic Metastasis 12/2021
1	Osteosarcoma (Osteogenic Sarcoma) 12/2021
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 10/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 09/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2019
1	Body Weight (Weight, Body) 10/2018
1	Pancreatitis 10/2018
1	Squamous Cell Carcinoma of Head and Neck 12/2017
1	Mouth Neoplasms (Oral Cancer) 12/2017
1	Brain Neoplasms (Brain Tumor) 12/2017
1	Lung Neoplasms (Lung Cancer) 12/2017
1	Esophageal Neoplasms (Esophageal Cancer) 12/2017
1	Mesothelioma 12/2017
1	Myasthenia Gravis 01/2017
1	Thymoma (Thymic Carcinoma) 01/2017
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 01/2017
1	Sarcoma (Soft Tissue Sarcoma) 01/2017
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2016
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 11/2015
1	Cystitis 04/2015
1	Transitional Cell Carcinoma 04/2015
1	Urinary Bladder Neoplasms (Bladder Cancer) 04/2015
1	Inflammation (Inflammations) 09/2014
1	Hyperplasia 03/2014
1	Hepatocellular Carcinoma (Hepatoma) 03/2014
1	Granuloma 12/2013

Drug/Important Bio-Agent (IBA)

6	LigandsIBA 02/2021 - 01/2014
6	Proteins (Proteins, Gene)FDA Link 06/2019 - 07/2007
4	AntibodiesIBA 01/2018 - 10/2007
3	Monoclonal AntibodiesIBA 02/2021 - 12/2016
3	ParaffinIBA 09/2019 - 01/2012
3	AntigensIBA 01/2016 - 10/2007
2	CollagenIBA 05/2022 - 01/2013
2	Prednisolone (Predate)FDA LinkGeneric 11/2021 - 10/2018
2	Glycoproteins (Glycoprotein)IBA 10/2020 - 12/2017
2	Formaldehyde (Formol)FDA Link 09/2019 - 09/2015
2	Toll-Like Receptors (Toll-Like Receptor)IBA 06/2017 - 08/2013
2	HLA-DR Antigens (HLA-DR)IBA 05/2016 - 01/2011
2	Messenger RNA (mRNA)IBA 04/2015 - 08/2013
2	Cell Adhesion MoleculesIBA 09/2014 - 08/2013
2	Indicators and Reagents (Reagents)IBA 01/2012 - 05/2008
2	Inhibins (Inhibin)IBA 10/2007 - 07/2007
2	DesminIBA 10/2007 - 07/2007
2	placental alkaline phosphataseIBA 10/2007 - 07/2007
1	Insulin (Novolin)FDA Link 03/2022
1	toceranib phosphateIBA 10/2021
1	Leucine (L-Leucine)FDA Link 10/2020
1	IgKIBA 09/2019
1	DNA (Deoxyribonucleic Acid)IBA 09/2019
1	Immunoglobulins (Immunoglobulin)IBA 09/2019
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 09/2019
1	Amino Acids FDA Link 07/2019
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2018
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2018
1	Dinoprostone (PGE2)FDA Link 01/2018
1	Tuberculin (PPD)IBA 01/2018
1	Interferon-gamma (Interferon, gamma)IBA 01/2018
1	C-Type Lectins (C-Type Lectin)IBA 12/2017
1	Cholinergic ReceptorsIBA 01/2017
1	Immune Checkpoint ProteinsIBA 01/2017
1	Blocking AntibodiesIBA 01/2017
1	Coloring Agents (Dyes)IBA 12/2016
1	EpitopesIBA 10/2016
1	Muramidase (Lysozyme)IBA 05/2016
1	Immune Checkpoint InhibitorsIBA 01/2016
1	Imatinib Mesylate (Gleevec)FDA Link 11/2015
1	Complementary DNA (cDNA)IBA 11/2015
1	ChromatinIBA 04/2015
1	Nuclear Proteins (Protein, Nuclear)IBA 04/2015
1	Small Interfering RNA (siRNA)IBA 04/2015
1	SelectinsIBA 09/2014
1	P-selectin ligand proteinIBA 09/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2014
1	Growth Factor ReceptorsIBA 03/2014
1	B7-H1 AntigenIBA 01/2014
1	milbemycin oxime (Interceptor)IBA 12/2013
1	NF-kappa B (NF-kB)IBA 08/2013
1	CytokinesIBA 08/2013
1	Pattern Recognition ReceptorsIBA 08/2013

Therapy/Procedure

5	Therapeutics 12/2017 - 07/2013
3	Immunotherapy 02/2021 - 01/2016
2	Molecular Targeted Therapy 12/2017 - 05/2016
1	Surgical Amputation (Amputations) 12/2021
1	Radiotherapy 11/2021
1	Aftercare (After-Treatment) 10/2018
1	Thymectomy 01/2017